Navigation Links
Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology

n of a first clinical candidate, and has added significantly to the understanding of the activities of HMGB1.

Critical Therapeutics has a strong HMGB1 intellectual property position that includes 6 U.S. and 17 foreign patents that have issued and 15 U.S. and 53 foreign patents that are currently pending issuance. Critical Therapeutics' HMGB1 patent estate is exclusively licensed to MedImmune for the treatment and prevention of diseases, such as arthritis and lupus. In addition, Critical Therapeutics licensed its HMGB1 diagnostic rights to Beckman Coulter, Inc., which is developing immunoassays to detect and manage inflammatory diseases.

About HMGB1

HMGB1, a pro-inflammatory protein secreted by different cell types, is part of the body's response to trauma and infection. HMGB1 is expressed at high levels beginning 12 to 72 hours after an injury, which is about the time inflammation-associated tissue damage begins. Because of the timing and duration of expression of HMGB1, it may be an important factor in the sequence of events that result in severe tissue damage following injury or during chronic inflammation.

About Arthritis(1)

Arthritis is a term that describes a group of more than 100 medical conditions that collectively affect nearly 70 million adults and 300,000 children in the United States alone. All of these conditions affect the musculoskeletal system and specifically the joints - where two or more bones meet. Arthritis-related joint problems include pain, stiffness, inflammation and damage to joint cartilage and surrounding structures. Rheumatoid arthritis is one of the most serious and disabling forms of the disease, affecting about 2.1 million Americans.

About Lupus(2)

Lupus is a widespread and chronic autoimmune disease that causes the immune system to attack the body's tissue and organs, including the joints, kidneys, heart, lungs, brain, blood, or skin. Approximately 1.5 million Americans have a form of
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
3. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
4. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
5. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
6. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
7. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
10. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients

Post Your Comments:
(Date:11/6/2009)...re/ -- Facet Solutions, Inc. announced today that ...edics. The acquisition creates an undisputed leade...property and clinical experience in posterior moti...ring from lumbar spinal stenosis," stated Facet So...consolidation further strengthens Facet Solutions,...
(Date:11/6/2009)...re/ -- Philips Respironics applauds the efforts of...DC) to raise awareness about an important public h...C,s release of the first-ever government study to ...s is a milestone in quantifying the size and scope...ndustry leader and sleep therapy manufacturer, Phi...
(Date:11/6/2009)... 6 Chimerix, Inc., a biopharmaceut...therapeutics to address life-threatening diseases,...ny,s lead antiviral compound, CMX001, to the World...ecurity Initiative (GHSI). CMX001 is a broad-spec...ment of smallpox, as well as other serious viral i...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 1Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 2Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 4Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 1Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 1Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 3
...ed Alone and in Combination with Chemotherapy, FR..., a,development-stage pharmaceutical company disco...)-based therapeutics, today announced that the,jou... of siRNA targeting,its proprietary target gene ag...ition dated October 1, 2008. The paper, entitled "...
...ASHINGTON, Oct. 12 Boston,Scientific Corporation ...ysis,of nearly 7,500 patients from its TAXUS ARRIV...m the performance of the TAXUS(R) Express2(TM),Pac...d practice. The,two-year pooled ARRIVE data showed...in patients with diabetes as effectively as in pat...
Other Medicine Technology:Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5
(Date:11/8/2009)...ire/ -- Speaker Nancy Pelosi and Democratic leader...age of H.R. 3962, the Affordable Health Care for A...15. Below are the Speaker,s opening remarks: ,...ll from the President of the United States, Barack...he American people. I thank the President for his ...
(Date:11/8/2009)...s is pleased to announce that it has been successf...ound who recently received an award on the $800 mi...ncludes not only the Veterans Administration, but ...gencies. , New York, NY (...pleased to announce that it has been successful in...
(Date:11/8/2009)... in the Western District of Pennsylvania award a F...ng for a medical malpractice case. Attorneys Thom...mas E. Crenney and Associates, LLC handled the cas... against the Uniontown Hospital. The woman had to... age 18. , Pittsburgh, PA...
(Date:11/8/2009)...health advocates committed to achieving meaningful.... 7 "Tonight the U.S. H... voice of America,s families by passing the Afford...ust deliver, without delay, on the promise of mean...do, President and CEO of the National Alliance for...
(Date:11/8/2009)...to Secure the Stability of Medicare ,, HOUSTON...ibutable to: J. James Rohack, M.D., President, Ame...ww.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...h reform bill, which will help improve the health ...wift passage of H.R. 3961 to secure the stability ...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
... ‘present’ - the common cause of amnesia, also pre...ing them to live only in the present. Researc...f Proceedings of the National Academy of Sciences ...rucial in learning and memory. Though, it has...
...bout having a child, it’s a research they will bac...ospital plan the first uterus transplant with the ...medical adventure is not without ethical controve...ient gives birth so she would not need anti-reject...
...alia health providers is busy counting its losses....ve had their doctors resort to rorting or over ser...procedures that were not necessary. The loss in...s at inappropriate practices such as over-servicin...
...rge family may not be best for your health. A new ...e development of stomach cancer linked to the bact...from large families appeared to be especially vuln...re followed over a 28-year period. The researchers...
...d a structural protein called nestin to a particul...ew biomarker that could lead to earlier detection ...sue of Cancer Research, researchers from Dartmouth...ith similarities to mammary stem cells, the regene...
...ening of adults age 50 or older appears to be as c...er screening programs, according to an article in ... Melanoma is the only cancer for which incidence...cle. Treating melanoma costs more than $740 millio...
Other Medicine News:Health News:Amnesia Halts Future Thinking: Study 2Health News:Uterus Transplant- A Future Reality 2Health News:Link Between Family Size and Stomach Cancer Found 2Health News:Link Between Family Size and Stomach Cancer Found 3Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 3Health News:One-time Melanoma Screening Appears to Be Cost-effective for Elderly People 2
OHL Periosteal Elevator
Steinhauser Periosteal Elevator
Dolwick-Reich Condyle Periosteal Elevator
Molt Periosteal Elevator
Medicine Products: